Novavax

Recent news

• Rating change
  H.C. Wainwright Maintains Novavax(NVAX.US) With Buy Rating, Maintains Target Price $16
  Market Newswire · 2026/4/21
• Rating change
  B. Riley Raises Price Target on Novavax to $18 From $16, Keeps Buy Rating
  MT Newswires · 2026/4/9
• Rating change
  BTIG Maintains Novavax(NVAX.US) With Buy Rating, Maintains Target Price $19
  Market Newswire · 2026/6/12
• Company notice
  Novavax | 4: Statement of changes in beneficial ownership of securities-Director Shiver John W.
  SEC · 2026/6/24
• Rating change
  H.C. Wainwright Maintains Novavax(NVAX.US) With Buy Rating, Raises Target Price to $16
  Market Newswire · 2026/2/27
• BofA Securities Maintains Novavax(NVAX.US) With Sell Rating, Maintains Target Price $8
  Market Newswire · 2026/7/7
• Company notice
  Novavax | 4: Statement of changes in beneficial ownership of securities-Director King Rachel K.
  SEC · 2026/6/24
• Rating change
  B. Riley Securities Maintains Novavax(NVAX.US) With Buy Rating, Raises Target Price to $18
  Market Newswire · 2026/4/9
• Cantor Fitzgerald Maintains Novavax(NVAX.US) With Buy Rating, Maintains Target Price $18
  Market Newswire · 2026/8/8
• Company notice
  Novavax | 4: Statement of changes in beneficial ownership of securities-Director Newton Charles W.
  SEC · 2026/6/24
• Rating change
  TD Cowen Initiates Novavax(NVAX.US) With Hold Rating, Announces Target Price $9
  Market Newswire · 2026/5/6
• Rating change
  TD Cowen Maintains Novavax(NVAX.US) With Hold Rating, Raises Target Price to $9
  Market Newswire · 2026/5/6
• Rating change
  BofA Securities Maintains Novavax(NVAX.US) With Sell Rating, Raises Target Price to $8
  Market Newswire · 2026/2/27
• Company notice
  Novavax | 4: Statement of changes in beneficial ownership of securities-Director Newton Charles W.
  SEC · 2026/4/29
• TD Cowen Maintains Novavax(NVAX.US) With Hold Rating, Maintains Target Price $9
  Market Newswire · 2026/8/4
• Rating change
  BofA Securities Maintains Novavax(NVAX.US) With Sell Rating, Maintains Target Price $7
  Market Newswire · 2026/2/13
• BofA Securities Maintains Novavax(NVAX.US) With Sell Rating, Cuts Target Price to $7
  Market Newswire · 2026/8/7
• Rating change
  Citi Maintains Novavax(NVAX.US) With Sell Rating, Raises Target Price to $7
  Market Newswire · 2026/2/27
• Company notice
  Novavax | 4: Statement of changes in beneficial ownership of securities-Director Shiver John W.
  SEC · 2026/3/13
• Earnings Flash (NVAX) Novavax Posts Q2 Net Loss of $0.32 a Share, Vs. FactSet Est. of $0.38 Loss
  MT Newswires · 2026/8/6

Headlines are aggregated automatically and are not independently verified or edited by our team.